Literature DB >> 12712430

Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life.

Christopher J Roberts1, Richard T Darrington, Maureen B Whitley.   

Abstract

The kinetics of irreversible aggregation of bovine Granulocyte-Colony Stimulating Factor (bG-CSF) in solution were investigated as a function of temperature (T), concentration, and pH, and analyzed in terms of an Extended Lumry-Eyring model of protein aggregation proceeding via a non-native conformational state. In the spirit of classic Lumry-Eyring models, the observed kinetics are separated into contributions from thermodynamic or conformational stability of unaggregated native and non-native states, and the intrinsic aggregation kinetics of non-native molecules. It is found that a detailed treatment of the intrinsic kinetics coupled with a two-state approximation of the reversible unfolding transition is sufficient to allow quantitative prediction of low-T stability from high-T data despite highly non-Arrhenius kinetics. Accounting for shifts in conformational equilibrium quantitatively captures the non-Arrhenius T dependence, without requiring the assumption of a change in the rate-determining step with T. From a more general perspective, the observed aggregation behavior of bG-CSF is consistent with the rate-determining step being aggregation at T below a crossover temperature T(x) that is inversely related to initial protein concentration. Above T(x), irreversible unfolding is presumably the rate-determining step. The results illustrate that protein aggregation kinetics can, in principle, be predicted quantitatively from so-called accelerated data provided the thermodynamic and kinetic components can be separately extrapolated to longer term storage conditions. Copyright 2003 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 92:1095-1111, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12712430     DOI: 10.1002/jps.10377

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  18 in total

1.  Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1.

Authors:  Haixia Wu; Kristopher Truncali; Julie Ritchie; Rachel Kroe-Barrett; Sanjaya Singh; Anne S Robinson; Christopher J Roberts
Journal:  MAbs       Date:  2015-08-12       Impact factor: 5.857

2.  Protein structural conformation and not second virial coefficient relates to long-term irreversible aggregation of a monoclonal antibody and ovalbumin in solution.

Authors:  Harminder Bajaj; Vikas K Sharma; Advait Badkar; David Zeng; Sandeep Nema; Devendra S Kalonia
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

3.  Nonnative protein polymers: structure, morphology, and relation to nucleation and growth.

Authors:  William F Weiss; Travis K Hodgdon; Eric W Kaler; Abraham M Lenhoff; Christopher J Roberts
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

4.  Structure and thermodynamics of colloidal protein cluster formation: comparison of square-well and simple dipolar models.

Authors:  Teresa M Young; Christopher J Roberts
Journal:  J Chem Phys       Date:  2009-09-28       Impact factor: 3.488

5.  Commentary: current perspectives on the aggregation of protein drugs.

Authors:  Elizabeth M Topp
Journal:  AAPS J       Date:  2014-02-22       Impact factor: 4.009

6.  High-pressure studies of aggregation of recombinant human interleukin-1 receptor antagonist: thermodynamics, kinetics, and application to accelerated formulation studies.

Authors:  Matthew B Seefeldt; Yong-Sung Kim; Kevin P Tolley; Jim Seely; John F Carpenter; Theodore W Randolph
Journal:  Protein Sci       Date:  2005-08-04       Impact factor: 6.725

7.  A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.

Authors:  Geetha Thiagarajan; Andrew Semple; Jose K James; Jason K Cheung; Mohammed Shameem
Journal:  MAbs       Date:  2016-05-21       Impact factor: 5.857

8.  Modification of the kinetic stability of immunoglobulin G by solvent additives.

Authors:  Jonas V Schaefer; Erik Sedlák; Florian Kast; Michal Nemergut; Andreas Plückthun
Journal:  MAbs       Date:  2018-04-25       Impact factor: 5.857

9.  Parallel chromatography and in situ scattering to interrogate competing protein aggregation pathways.

Authors:  Diana Gomes; Rebecca K Kalman; Rebecca K Pagels; Miguel A Rodrigues; Christopher J Roberts
Journal:  Protein Sci       Date:  2018-06-13       Impact factor: 6.725

Review 10.  Non-Arrhenius protein aggregation.

Authors:  Wei Wang; Christopher J Roberts
Journal:  AAPS J       Date:  2013-04-25       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.